AI aims to help babies born addicted to opioids
NCT ID NCT06303986
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 29 times
Summary
This study gathers health data from 100 newborns, including 80 with neonatal abstinence syndrome (NAS) and 20 healthy babies. The goal is to use this data to train an artificial intelligence (AI) system that can automatically score NAS symptoms and help doctors make better treatment decisions. The study does not test a new drug or treatment—it focuses on improving how we monitor and assess these babies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL ABSTINENCE SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of New Mexico
Albuquerque, New Mexico, 87106, United States
Conditions
Explore the condition pages connected to this study.